IGX — Intelgenx Technologies Share Price
0.000.00%
Last trade - 00:00- CA$41.92m
- CA$62.83m
- $1.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 29.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -852.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.74 | 1.54 | 1.53 | 0.95 | 1.04 | n/a | n/a | -10.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet medical needs. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Its manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. Its product portfolio includes Migraine (Rizatriptan), Erectile Dysfunction (Tadalafil), Schizophrenia (Lozapine), Neurodegenerative, Opioid Dependence (Buprenorphine / Naloxone) and others.
Directors
- Horst Zerbe CHM (74)
- Andre Godin PRE (58)
- J. Bernard Boudreau NVC (76)
- Rodolphe Obeid VOP (41)
- Tommy Kenny VPR
- Nadine Paiement VRD (44)
- Dana Matzen VBD (43)
- Ingrid Zerbe SEC (66)
- Srinivas Rao DRC
- Frank Stegert DRC
- John Marinucci IND (64)
- Clemens Mayr IND (53)
- Bernd Melchers IND (69)
- Mark Nawacki IND (52)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- July 27th, 1999
- Public Since
- May 23rd, 2008
- No. of Shareholders
- 49
- No. of Employees
- 48
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 174,658,096
- Address
- 6420 Abrams St, SAINT-LAURENT, H4S 1Y2
- Web
- https://www.intelgenx.com/
- Phone
- +1 5143317440
- Contact
- Stephen Kilmer
- Auditors
- Richter LLP
Upcoming Events for IGX
Q3 2024 Intelgenx Technologies Corp Earnings Release
Similar to IGX
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
Charlotte's Web Holdings
Toronto Stock Exchange
FAQ
What is the Intelgenx Technologies share price?
As of Today at 21:23 UTC, shares in Intelgenx Technologies are trading at CA$0.24. This share price information is delayed by 15 minutes.
How has the Intelgenx Technologies share price performed this year?
Shares in Intelgenx Technologies last closed at CA$0.24 and the price had moved by +33.33% over the past 365 days. In terms of relative price strength the Intelgenx Technologies share price has outperformed the Toronto Stock Exchange 300 Composite Index by +20.12% over the past year.
What are the analyst and broker recommendations for Intelgenx Technologies?
The overall consensus recommendation for Intelgenx Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Intelgenx Technologies dividend yield?
Intelgenx Technologies does not currently pay a dividend.
Does Intelgenx Technologies pay a dividend?
Intelgenx Technologies does not currently pay a dividend.
When does Intelgenx Technologies next pay dividends?
Intelgenx Technologies does not currently pay a dividend.
How do I buy Intelgenx Technologies shares?
To buy shares in Intelgenx Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Intelgenx Technologies?
As of the previous close price of CA$0.24, shares in Intelgenx Technologies had a market capitalisation of CA$41.92m.
Where are Intelgenx Technologies shares listed?
Here are the trading details for Intelgenx Technologies:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: IGX
What kind of share is Intelgenx Technologies?
Based on an overall assessment of its quality, value and momentum Intelgenx Technologies is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Intelgenx Technologies share price forecast for 2024?
The analyst consensus target price for shares in Intelgenx Technologies is CA$1.00. That is 316.53% above the last closing price of CA$0.24.
Analysts covering Intelgenx Technologies currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
What is the trend in the Intelgenx Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Intelgenx Technologies. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +23.16%.
As of the last closing price of CA$0.24, shares in Intelgenx Technologies were trading +14.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Intelgenx Technologies PE Ratio?
The Intelgenx Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Intelgenx Technologies?
Intelgenx Technologies' management team is headed by:
- Horst Zerbe - CHM
- Andre Godin - PRE
- J. Bernard Boudreau - NVC
- Rodolphe Obeid - VOP
- Tommy Kenny - VPR
- Nadine Paiement - VRD
- Dana Matzen - VBD
- Ingrid Zerbe - SEC
- Srinivas Rao - DRC
- Frank Stegert - DRC
- John Marinucci - IND
- Clemens Mayr - IND
- Bernd Melchers - IND
- Mark Nawacki - IND